Therapeutic Asset Ratings
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Empagliflozin
Metabolic Dysfunction-Associated Steatotic Liver Disease
Justin Ryder
P4
BBB
(76)
Evomela
Diffuse Large B-Cell Lymphoma
Ruijin Hospital
P4
BBB
(76)
FACTOR VIII (HUMAN)
Hemophilia A
Hoffmann-La Roche
P4
BBB
(76)
FILGRASTIM
Neutropenia
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P4
BBB
(76)
Fitusiran
Hemophilia A
Sanofi
P4
BBB
(76)
Fludarabine
Recurrent Adult Diffuse Large Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P4
BBB
(76)
Folic Acid
Hyperhomocysteinemia
Shenzhen Ausa Pharmed Co.,Ltd
P4
BBB
(76)
Gardasil 9 Vaccine
Human Papilloma Virus Infection
Eunice Dube
P4
BBB
(76)
Idarubicine
Adult Acute Lymphoblastic Leukemia
Shanxi Bethune Hospital
P4
BBB
(76)
Ifosfamide
Primary Mediastinal Large B-Cell Lymphoma
David Bond, MD
P4
BBB
(76)
IMMUNOGLOBULIN G1, ANTI-(HUMANIZED MOUSE MONOCLONAL HR3 .BETA.1 CHAIN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR), DISULFIDE WITH HUMANIZED MOUSE MONOCLONAL HR3 .KAPPA.-CHAIN, DIMER
Malignant Pancreatic Neoplasm
Chinese PLA General Hospital
P4
BBB
(76)
Inno-206
Hematopoietic And Lymphoid System Neoplasm
OHSU Knight Cancer Institute
P4
BBB
(76)
Inno-206
Recurrent Adult T-cell Leukemia/Lymphoma
National Cancer Institute (NCI)
P4
BBB
(76)
Letrozole
Diabetes Mellitus, Type 2
ARKAY Therapeutics
P4
BBB
(76)
LIDOCAINE
Post-Operative Pain, Non-Human Animal
Instituto Mexicano del Seguro Social
P4
BBB
(76)
Lipitor
Cardiovascular Disorder
Duke University
P4
BBB
(76)
Liraglutide
Cardiovascular Disorder
University of Sao Paulo General Hospital
P4
BBB
(76)
Losartan
Hypertensive Disorder
Rong Zhang
P4
BBB
(76)
Lurasidone
Schizophrenia
Aziende Chimiche Riunite Angelini Francesco S.p.A
P4
BBB
(76)
Metformin
Glucose Metabolism Disease
SINA Health Education and Welfare Trust
P4
BBB
(76)
METHOTREXATE
Recurrent Adult Acute Lymphoblastic Leukemia
Shanxi Bethune Hospital
P4
BBB
(76)
Methylphenidate
Attention Deficit-Hyperactivity Disorder
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
P4
BBB
(76)
Ocrevus
Relapsing-Remitting Multiple Sclerosis
Biocad
P4
BBB
(76)
Ocrevus
Primary Progressive Multiple Sclerosis
Indapta Therapeutics, INC.
P4
BBB
(76)
Omalizumab
Allergic Asthma
Qianfoshan Hospital
P4
BBB
(76)
Showing 276 to 300 of 61,847 assets
Previous
Page 12 of 2474
Next